Patient Rights and Informed Consent in Clinical Trials

Core Ethical Framework

• The American College of Physicians and other medical societies emphasize that research participants are subject to risk and thus require informed consent with specific protections, as established by the Belmont Report in 1979 1, 2

Essential Patient Rights in This Trial

• Patients have the right to withdraw from the trial at any time without penalty or loss of standard care, which is absolute and fundamental to ethical research participation 1, 2
• Patients must receive an explanation of all research procedures, assessments, and instruments used in the study, presented in a manner that is easy for them to understand 2
• Patients should be informed about how and when they will receive information about study results, as part of the comprehensive informed consent process 2

Critical Informed Consent Components

• The purpose of the research is to develop generalizable knowledge, not necessarily to benefit individual patients, and the safety and effectiveness of the new intervention is unclear 1, 2
• Patients will be randomized to receive either the new drug or placebo, and participation is voluntary, with the option to withdraw at any time 1, 2
• The loss of privacy and confidentiality during clinical record review is a potential risk of participation 3

Common Pitfalls to Avoid

• Patients must understand they are participating in research, not receiving standard treatment, and the goal is scientific knowledge, not optimizing their individual care 1, 2

Data Usage After Withdrawal

• Even if a patient withdraws, data collected up to that point typically remains in the research database, as required by the FDA to determine safety and effectiveness 4